CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
GDF2; Growth Differentiation Factor 2
- Product No.USCB728Ra
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range27.4-20,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 10.4pg/mL.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Download Instruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
-
FOB
US$ 319
For more details, please contact local distributors!US$ 456
For more details, please contact local distributors! US$ 2052
For more details, please contact local distributors! US$ 3876
For more details, please contact local distributors! US$ 31920
For more details, please contact local distributors!
-
Packages (Simulation)
-
Packages (Simulation)
-
Results demonstration
-
Typical Standard Curve
-
ISO9001: 2008, ISO13485: 2003 Registered
Specificity of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
This assay has high sensitivity and excellent specificity for detection of Bone Morphogenetic Protein 9 (BMP9).
No significant cross-reactivity or interference between Bone Morphogenetic Protein 9 (BMP9) and analogues was observed.
Recovery of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
Matrices listed below were spiked with certain level of recombinant Bone Morphogenetic Protein 9 (BMP9) and the recovery rates were calculated by comparing the measured value to the expected amount of Bone Morphogenetic Protein 9 (BMP9) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 94-102 | 99 |
| EDTA plasma(n=5) | 80-94 | 88 |
| heparin plasma(n=5) | 79-103 | 91 |
Precision of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Bone Morphogenetic Protein 9 (BMP9) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Bone Morphogenetic Protein 9 (BMP9) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Bone Morphogenetic Protein 9 (BMP9) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 98-105% | 78-103% | 83-96% | 80-89% |
| EDTA plasma(n=5) | 80-89% | 90-97% | 90-97% | 80-96% |
| heparin plasma(n=5) | 83-105% | 92-101% | 87-95% | 80-98% |
Stability of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
Test principle of the CLIA Kit for Bone Morphogenetic Protein 9 (BMP9)
The microplate provided in this kit has been pre-coated with an antibody specific to Bone Morphogenetic Protein 9 (BMP9). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Bone Morphogenetic Protein 9 (BMP9). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Bone Morphogenetic Protein 9 (BMP9) level in the sample or standard.;
GIVEAWAYS
INCREMENT SERVICES
Single-component Reagents of Assay Kit
Lysis Buffer Specific for ELISA / CLIA
Quality Control of Kit
CLIA Kit Customized Service
Disease Model Customized Service
Serums Customized Service
TGFB1 Activation Reagent
Real Time PCR Experimental Service
Streptavidin
Fast blue Protein Stain solution
Single-component Reagents of FLIA Kit
Streptavidin-Agarose Beads
Related products
| Catalog No. | Organism species: Rattus norvegicus (Rat) | Applications (RESEARCH USE ONLY!) |
| URPB728Ra01 | Recombinant Bone Morphogenetic Protein 9 (BMP9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB728Ra02 | Recombinant Bone Morphogenetic Protein 9 (BMP9) | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB728Ra01 | Polyclonal Antibody to Bone Morphogenetic Protein 9 (BMP9) | WB; IHC; ICC; IP. |
| UMAB728Ra21 | Monoclonal Antibody to Bone Morphogenetic Protein 9 (BMP9) | WB; IHC; ICC; IP. |
| USEB728Ra | ELISA Kit for Bone Morphogenetic Protein 9 (BMP9) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB728Ra | CLIA Kit for Bone Morphogenetic Protein 9 (BMP9) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB728Ra | Multiplex Assay Kit for Bone Morphogenetic Protein 9 (BMP9) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |